276 related articles for article (PubMed ID: 15934439)
1. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI.
Nagasawa K; Tada Y; Koarada S; Horiuchi T; Tsukamoto H; Murai K; Ueda A; Yoshizawa S; Ohta A
Lupus; 2005; 14(5):385-90. PubMed ID: 15934439
[TBL] [Abstract][Full Text] [Related]
2. Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant.
Nagasawa K; Tada Y; Koarada S; Tsukamoto H; Horiuchi T; Yoshizawa S; Murai K; Ueda A; Haruta Y; Ohta A
Lupus; 2006; 15(6):354-7. PubMed ID: 16830881
[TBL] [Abstract][Full Text] [Related]
3. High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.
Kuroda T; Tanabe N; Wakamatsu A; Takai C; Sato H; Nakatsue T; Wada Y; Nakano M; Narita I
Clin Rheumatol; 2015 Dec; 34(12):2071-7. PubMed ID: 26384821
[TBL] [Abstract][Full Text] [Related]
4. MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus.
Yang XY; Xu DH
Pharmazie; 2007 Dec; 62(12):930-2. PubMed ID: 18214345
[TBL] [Abstract][Full Text] [Related]
5. Recovery of the blood flow around the femoral head during early corticosteroid therapy: dynamic magnetic resonance imaging in systemic lupus erythematosus patients.
Nakamura J; Ohtori S; Watanabe A; Nakagawa K; Inoue G; Kishida S; Harada Y; Suzuki M; Takahashi K
Lupus; 2012 Mar; 21(3):264-70. PubMed ID: 22020268
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment.
Oinuma K; Harada Y; Nawata Y; Takabayashi K; Abe I; Kamikawa K; Moriya H
Ann Rheum Dis; 2001 Dec; 60(12):1145-8. PubMed ID: 11709458
[TBL] [Abstract][Full Text] [Related]
7. High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under steroid therapy.
Okazaki S; Nagoya S; Yamamoto M; Tateda K; Takahashi H; Yamashita T; Matsumoto H
Rheumatol Int; 2013 Jan; 33(1):51-5. PubMed ID: 22215042
[TBL] [Abstract][Full Text] [Related]
8. [Clinical condition of steroid-induced osteonecrosis of the femoral head].
Kubo T; Fujioka M; Ishida M
Clin Calcium; 2007 Jun; 17(6):856-62. PubMed ID: 17548924
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus.
Massardo L; Jacobelli S; Leissner M; González M; Villarroel L; Rivero S
Lupus; 1992 Dec; 1(6):401-5. PubMed ID: 1304409
[TBL] [Abstract][Full Text] [Related]
10. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment.
Koo KH; Kim R; Kim YS; Ahn IO; Cho SH; Song HR; Park YS; Kim H; Wang GJ
Clin Rheumatol; 2002 Aug; 21(4):299-303. PubMed ID: 12189457
[TBL] [Abstract][Full Text] [Related]
11. Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus.
Sekiya F; Yamaji K; Yang K; Tsuda H; Takasaki Y
Rheumatol Int; 2010 Nov; 30(12):1587-93. PubMed ID: 19809818
[TBL] [Abstract][Full Text] [Related]
12. Prognostication of osteonecrosis of the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging.
Sugano N; Ohzono K; Masuhara K; Takaoka K; Ono K
Clin Orthop Relat Res; 1994 Aug; (305):190-9. PubMed ID: 8050228
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of femoral head in SLE patient after short period of corticosteroid therapy--a case report.
Memon S; Rab SM
J Pak Med Assoc; 1991 Aug; 41(8):197-8. PubMed ID: 1942485
[No Abstract] [Full Text] [Related]
14. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan.
Sakaguchi M; Tanaka T; Fukushima W; Kubo T; Hirota Y;
J Orthop Sci; 2010 Mar; 15(2):185-91. PubMed ID: 20358330
[TBL] [Abstract][Full Text] [Related]
15. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study.
Shigemura T; Nakamura J; Kishida S; Harada Y; Ohtori S; Kamikawa K; Ochiai N; Takahashi K
Rheumatology (Oxford); 2011 Nov; 50(11):2023-8. PubMed ID: 21865285
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI.
Nakamura J; Harada Y; Oinuma K; Iida S; Kishida S; Takahashi K
Lupus; 2010 Oct; 19(11):1307-14. PubMed ID: 20605878
[TBL] [Abstract][Full Text] [Related]
17. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant.
Hirata T; Fujioka M; Takahashi KA; Asano T; Ishida M; Akioka K; Okamoto M; Yoshimura N; Satomi Y; Nishino H; Hirota Y; Nakajima S; Kato S; Kubo T
J Rheumatol; 2007 Mar; 34(3):516-22. PubMed ID: 17143965
[TBL] [Abstract][Full Text] [Related]
19. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.
Fialho SC; Bonfá E; Vitule LF; D'Amico E; Caparbo V; Gualandro S; Pereira RM
Lupus; 2007; 16(4):239-44. PubMed ID: 17439929
[TBL] [Abstract][Full Text] [Related]
20. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
